We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Zebrafish Model Provides Clues to Arterial Development

By Biotechdaily staff writers
Posted on 19 Jun 2003
Researchers have utilized transgenic zebrafish embryos with fluorescently labeled blood vessels to identify and characterize a mutant fish (y10) that lacks the gene for synthesis of phopholipase C gamma-1 protein (Plcg1) and displays specific defects in the formation of arteries but not veins.

Investigators at the US National Institutes of Health (Bethesda, MD, USA) worked with transparent zebrafish embryos, a well-established model system for development of vertebrates. More...
By labeling blood vessels with a fluorescent marker they could observe vessel formation during development. Their report in the June 1, 2003, issue of Genes & Development described the y10 mutant, which appeared to lack arteries but had ostensibly normal veins. The gene responsible for the y10 mutant phenotype was found to code for Plcg1, a known effector of receptor tyrosine kinase signaling found in a number of vertebrate species, including mammals.

The y10 mutant embryos failed to respond to added vascular endothelial growth factor (Vegf), indicating that Plcg1 functioned specifically downstream of the Vegf receptor during embryonic development to govern formation of the arterial system.

First author Dr. Nathan Lawson, now an assistant professor of molecular medicine at the University of Massachusetts Medical School (Worcester, USA; www.umassmed.edu) explained, "Until recently, we really did not know what the signals were that determined artery and venous identity, or even that this process was governed by genetic signals. It was always thought that circulatory flow and pressure caused a blood vessel to be an artery or a vein. I think an important implication of this work is that the signals that drive this process appear to be the same in fish and mammals. For that reason we think it is likely that what we learn about zebrafish blood vessels may help us manipulate the growth of human blood vessels in a variety of disease processes, including diabetes and cancer.”





Related Links:
National Institutes of Health
University of Massachusetts Medical School

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.